Indication: Diabetic Macular Edema
Physician conducting the study: Thomas Essman, M.D.
Study ID: 206207
Study Status: Enrolling new patients
The retina is the light-sensitive tissue at the back of the eye.  The macula is a tiny oval area located at the center of the retina, and is responsible for central vision.  A healthy macula is necessary for tasks requiring detailed vision, such as reading.  Macular edema is a build up of fluid causing swelling in the macula resulting in reduced central vision.  Diabetes is one cause of macular edema. 

The purpose of this study is to research the use of an investigational drug applicator system to deliver medication to the back of the eye to treat macular edema.  The applicator system is surgically implanted and slowly releases the drug as the applicator dissolves over time.

For more information about this study, please contact Pearlena Hamlet at (417) 820-9742.
 

Indication: Keratoconus
Physician conducting the study: Shachar Tauber, M.D.
Study ID: Keratoconus
Study Status: Not yet started
Keratoconus is a corneal disease that occurs when the normally round dome-shaped cornea (the clear outer area of your eye) progressively thins causing a cone-like bulge to develop.  An abnormally shaped cornea can create reduced visual acuity, making simple daily tasks such as driving, reading, or watching TV difficult. 

The purpose of this research is to study the effectiveness of INTACS, which are prescription inserts used for the correction of low levels of nearsightedness, in the treatment of keratoconus.  INTACS are two small, plastic crescents that are designed to remain permanently in the eye.  The procedure for inserting INTACS is typically performed on an outpatient basis.  Additional clinical data suggests that INTACS are safe not just for correcting nearsightedness, but also for the treatment of keratoconus.

For more information about this study, please contact Pearlena Hamlet at (417) 820-9742.